Drug intelligence / Profile preview

HMW1 + HMW2

Development stage
Preclinical
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Subcutaneous, Intranasal
01

Overview

HMW1 + HMW2 is an experimental **protein subunit vaccine antigen combination** comprising the nontypeable *Haemophilus influenzae* high-molecular-weight adhesins HMW1 and HMW2. These surface-exposed bacterial adhesins are major colonization factors and vaccine-candidate antigens intended to induce antibodies that block adherence of nontypeable *H. influenzae* to respiratory epithelium, promote bacterial agglutination and opsonophagocytic killing, and thereby reduce nasopharyngeal colonization and subsequent respiratory disease. The combination has been investigated in preclinical studies, including recombinant protein immunization and adenoviral expression approaches, as a candidate vaccine strategy for prevention of infections caused by nontypeable *H. influenzae*, which is implicated in otitis media and exacerbations of chronic obstructive pulmonary disease.

Other names
HMW1 + HMW2high-molecular-weight adhesin 1 + high-molecular-weight adhesin 2
02

Targets

HMW2 (High-molecular-weight adhesin 2)HMW1 (High-molecular-weight adhesin 1)

Beyond the preview

Go deeper on HMW1 + HMW2.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HMW1 + HMW2.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call